Gram-negative bacterial outer membrane lipid A (Lipid A)

Gram-negative bacterial outer membrane lipid A is a highly conserved saccharolipid that serves as the essential hydrophobic anchor for lipopolysaccharide (LPS) in the outer leaflet of the bacterial cell envelope [2, 5, 17]. It plays a fundamental role in maintaining the structural integrity and selective permeability of the outer membrane, acting as a barrier against toxic compounds and host defense mechanisms [5, 6]. In clinical medicine, lipid A is primarily known as a potent endotoxin; its recognition by the human Toll-like receptor 4 (TLR4)/MD2 complex triggers a robust innate immune response [2, 17]. While this activation is crucial for detecting and clearing bacterial pathogens, an overactive response can lead to systemic inflammation, vascular collapse, and life-threatening septic shock [2, 17]. Lipid A is a direct therapeutic target for polymyxin antibiotics, such as colistin and polymyxin B, which bind to its negatively charged phosphate groups to disrupt the bacterial membrane [6]. Furthermore, the lipid A biosynthetic pathway (the Raetz pathway) is a major focus for the development of novel antibiotics designed to combat multidrug-resistant Gram-negative infections [1, 3, 8].

Other names

EndotoxinLipid A moietyLPS lipid ALipid A componentRaetz pathway product

Polymyxin antibiotics bind directly to the negatively charged phosphate groups of lipid A, displacing stabilizing divalent cations and disrupting the integrity of the bacterial outer membrane [6]. Additionally, lipid A analogs like eritoran act as competitive antagonists of the TLR4/MD2 receptor complex, preventing the initiation of the inflammatory signaling cascade triggered by bacterial endotoxins [2, 17].